definiens: shall mean any confidential or proprietary informat ion of a Party relating to any assay, diagnostic, biomarker, genet ic sequence, compound, research project, work in process, future development, scientific, engineerin g, launch, manufacturing, marketing, business plan, financial or personnel matter relating to suc h Party, its present or future products, sales, suppliers, customers, employees, investors or busin ess, including the results arising from this Agreement, whether in oral, written, graphic or ele ctronic form, that is disclosed by or on behalf of a Party to another Party, or becomes known to a Party as a consequence of performing Activities under this Agreement . Notwithstanding the foregoing, Tokai shall be the disclosing Party with respect to Clinical Data, Biomarker Data, Tokai Bac kground Intellectual Property and Tokai Foreground Intellectual Property, and QIAGEN shall be the disclosing Party with respect to Analytical Performance Data, QIAGEN Background Inte llectual Property and QIAGEN Foreground Intellectual Property, in each case regardless of t he Party that actually discloses such information